Response To Treatment With Mepolizumab In Elderly Patients

被引：0
|
作者：
Ortega, H. [1 ]
Mayer, B. [2 ]
Yancey, S. [1 ]
Katial, R. [3 ]
机构：
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] GlaxoSmithKline, Stockley Pk, England
[3] Natl Jewish Hlth, Denver, CO USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4177
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluating treatment response to mepolizumab in patients with severe CRSwNP
    Hopkins, Claire
    Han, Joseph K.
    Lund, Valerie J.
    Bachert, Claus
    Fokkens, Wytske J.
    Diamant, Zuzana
    Mullol, Joaquim
    Sousa, Ana R.
    Smith, Steven G.
    Yang, Shibing
    Mayer, Bhabita
    Yancey, Steve W.
    Chan, Robert H.
    Lee, Stella E.
    RHINOLOGY, 2023, 61 (02) : 108 - 117
  • [2] Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment
    Magnan, A.
    Bourdin, A.
    Prazma, C. M.
    Albers, F. C.
    Price, R. G.
    Yancey, S. W.
    Ortega, H.
    ALLERGY, 2016, 71 (09) : 1335 - 1344
  • [3] Characterising individual response to mepolizumab treatment
    Jackson, David
    Price, Robert G.
    Yancey, Steven W.
    Buhl, Roland
    Wenzel, Sally
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [4] Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
    Prazma, Charlene M.
    Idzko, Marco
    Douglass, Jo Anne
    Bourdin, Arnaud
    Mallett, Stephen
    Albers, Frank C.
    Yancey, Steven W.
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 675 - 683
  • [5] Real life data on treatment response to mepolizumab in patients with severe eosinophilic asthma
    Ntakoula, M.
    Fokoloros, C.
    Pasali, M.
    Aggelides, X.
    Makris, M.
    ALLERGY, 2019, 74 : 446 - 446
  • [6] TREATMENT OF ELDERLY PATIENTS WITH DELIRIUM - RESPONSE
    COLE, MG
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1995, 152 (03) : 324 - 325
  • [7] Treatment of patients with the hypereosinophilic syndrome with mepolizumab
    Rothenberg, Marc E.
    Klion, Amy D.
    Roufosse, Florence E.
    Kahn, Jean Emmanuel
    Weller, Peter F.
    Simon, Hans-Uwe
    Schwartz, Lawrence B.
    Rosenwasser, Lanny J.
    Ring, Johannes
    Griffin, Elaine F.
    Haig, Ann E.
    Frewer, Paul I. H.
    Parkin, Jacqueline M.
    Gleich, Gerald J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12): : 1215 - 1228
  • [8] Durability of mepolizumab treatment response between doses
    Pavord, Ian Douglas
    Howarth, Peter
    Bratton, Daniel J.
    Albers, Frank C.
    Yancey, Steven
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [9] Response to mepolizumab treatment in biologic-naive asthma patients and patients who received omalizumab
    Sasano, Hitoshi
    Harada, Norihiro
    Sato, Yoshihiko
    Sandhu, Yuuki
    Tanabe, Yuki
    Harada, Sonoko
    Jingo, Koichi
    Okuma, Tomoko
    Watanabe, Takayasu
    Kato, Yukari
    Nishimaki, Takayasu
    Abe, Sumiko
    Ueda, Shoko
    Goto, Ai
    Takeshige, Tomohito
    Matsuno, Kei
    Ito, Jun
    Nagaoka, Tetsutaro
    Atsuta, Ryo
    Takahashi, Kazuhisa
    RESPIROLOGY, 2023, 28 : 183 - 184
  • [10] Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma
    Hamada, Yuto
    Thomas, Dennis
    Harvey, Erin S.
    Stevens, Sean
    Fricker, Michael
    Lewthwaite, Hayley
    Mcdonald, Vanessa M.
    Gillman, Andrew
    Hew, Mark
    Kritikos, Vicky
    Upham, John W.
    Gibson, Peter G.
    EUROPEAN RESPIRATORY JOURNAL, 2025, 65 (01)
12345